Nicolas Sylvius

Nicolas Sylvius

Auto-generated profile, based on publicly available information

Nicolas Sylvius

Department of Genetics, University of Leicester, Leicester, United Kingdom

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in The American Journal of Human Genetics
Verified
Journal Article
Open access
MBMatthew J. Bown
Matthew J. Bown
GJGregory T. Jones
Gregory T. Jones
SHSeamus C. Harrison
Seamus C. Harrison
BWBenjamin J. Wright
Benjamin J. Wright
SBSuzannah Bumpstead
Suzannah Bumpstead
NSNilesh J. Samani
Nilesh J. Samani
Abdominal aortic aneurysm (AAA) is a common cause of morbidity and mortality and has a significant heritability. We carried out a genome-wide association discovery study of 1866 patients with AAA and 5435 controls and replication of promising signals (lead SNP with a p value < 1 × 10(-5)) in 2871 additional cases and 32,687 controls and performed further follow-up in 1491 AAA and 11,060 controls. In the discovery study, nine loci demonstrated association with AAA (p < 1 × 10(-5)). In the replication sample, the lead SNP at one of these loci, rs1466535, located within intron 1 of low-density-lipoprotein receptor-related protein 1 (LRP1) demonstrated significant association (p = 0.0042). We confirmed the association of rs1466535 and AAA in our follow-up study (p = 0.035). In a combined analysis (6228 AAA and 49182 controls), rs1466535 had a consistent effect size and direction in all sample sets (combined p = 4.52 × 10(-10), odds ratio 1.15 [1.10-1.21]). No associations were seen for either rs1466535 or the 12q13.3 locus in independent association studies of coronary artery disease, blood pressure, diabetes, or hyperlipidaemia, suggesting that this locus is specific to AAA. Gene-expression studies demonstrated a trend toward increased LRP1 expression for the rs1466535 CC genotype in arterial tissues; there was a significant (p = 0.029) 1.19-fold (1.04-1.36) increase in LRP1 expression in CC homozygotes compared to TT homozygotes in aortic adventitia. Functional studies demonstrated that rs1466535 might alter a SREBP-1 binding site and influence enhancer activity at the locus. In conclusion, this study has identified a biologically plausible genetic variant associated specifically with AAA, and we suggest that this variant has a possible functional role in LRP1 expression.

15 March 2005 in European Heart Journal
Verified
Journal Article
Open access
PDF file
EVEric Villard
Eric Villard
LDLaetitia Duboscq-Bidot
Laetitia Duboscq-Bidot
PCPhilippe Charron
Philippe Charron
ABAbdelaziz Benaiche
Abdelaziz Benaiche
VCViviane Conraads
Viviane Conraads
MKMichel Komajda
Michel Komajda
Aims Familial dilated cardiomyopathy (FDCM) is associated with mutations in more than 10 genes, but genes mutation frequencies and associated clinical features remain largely unknown. Here, we performed a mutation analysis of four genes involved in FDCM in a population of idiopathic DCM. Methods and results A SSCP and sequencing mutation screening of all the exons coding for beta myosin heavy chain (MYH7 gene), cardiac T troponin (TNNT2 gene), phospholamban (PLN gene), and the cardio-specific exon of metavinculin (VCL gene) were performed in 96 independent patients (54 familial and 42 sporadic). It led to the identification of eight heterozygous mutations, seven new ones in MYH7, and the already described R141W mutation in TNNT2. MYH7 mutations (in five familial and two sporadic cases) substitute residues located either in the head (I201T, T412N, A550V) or tail domains (T1019N, R1193S, E1426K, R1634S) of the protein. DCM was not associated with skeletal myopathy or conduction defects in any patients. Contrasting clinical features were observed between MYH7 and TNNT2 mutations carriers. In MYH7 vs. TNNT2, mean age at diagnosis was late (P<0.03), penetrance was incomplete in adults (56 vs. 100%), and mean age at major cardiac event was higher (P<0.04). Conclusion We have identified seven mutations in MYH7, one in TNNT2, and none in PLN or in the VCL cardio-specific exon. MYH7 appears as the most frequently mutated gene in our FDCM population (∼10%), and mutation carriers present with delayed onset, in contrast to TNNT2.

1 October 2013 in Circulation: Cardiovascular Genetics
Verified
Journal Article
Closed access
PDF file
PSPhilip W. Stather
Philip W. Stather
NSNicolas Sylvius
Nicolas Sylvius
JWJohn B. Wild
John B. Wild
ECEdward Choke
Edward Choke
RSRobert D. Sayers
Robert D. Sayers
MBMatthew J. Bown
Matthew J. Bown
Background—: Peripheral arterial disease (PAD) is a clinical condition caused by an atherosclerotic process affecting the arteries of the limbs. Despite major improvements in surgical endovascular techniques, PAD is still associated with high mortality and morbidity. Recently, microRNAs (miRNAs), a class of short noncoding RNA controlling gene expression, have emerged as major regulators of multiple biological processes. Methods and Results—: A whole-miRNA transcriptome profiling was performed in peripheral blood from an initial sample set of patients and controls. A 12-miRNA PAD-specific signature, which includes let 7e, miR-15b, -16, -20b, -25, -26b, -27b, -28-5p, -126, -195, -335, and -363, was further investigated and validated in 2 additional sample sets. Each of these 12 miRNAs exhibited good diagnostic value as evidenced by receiver operating characteristic curve analyses. Pathway enrichment analysis using predicted and validated targets identified several signaling pathways relevant to vascular disorders. Several of these pathways, including cell adhesion molecules, were confirmed by quantifying the expression level of several candidate genes regulating the initial stages of the inflammatory atherosclerotic process. The expression level of 7 of these candidate genes exhibits striking inverse correlation with that of several, if not all, of the miRNAs of the PAD-specific miRNA signature. Conclusions—: These results demonstrate the potential of miRNAs for the diagnosis of PAD and provide further insight into the molecular mechanisms leading to the development of PAD, with the potential for future therapeutic targets.

1 August 2005 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
NSN Sylvius
N Sylvius
ZBZofia T. Bilińska
Zofia T. Bilińska
JVJ P Veinot
J P Veinot
AFA Fidzianska
A Fidzianska
PBP M Bolongo
P M Bolongo
FTF Tesson
F Tesson
Context: Lamin A/C (LMNA) gene variations have been reported in more than one third of genotyped families with dilated cardiomyopathy (DCM). However, the relationship between LMNA mutation and the development of DCM is poorly understood. Methods and results: We found that end stage DCM patients carrying LMNA mutations displayed either dramatic ultrastructural changes of the cardiomyocyte nucleus (D192G) or nonspecific changes (R541S). Overexpression of the D192G lamin C dramatically increased the size of intranuclear speckles and reduced their number. This phenotype was only partially reversed by coexpression of the D192G and wild type lamin C. Moreover, the D192G mutation precludes insertion of lamin C into the nuclear envelope when co-transfected with the D192G lamin A. By contrast, the R541S phenotype was entirely reversed by coexpression of the R541S and wild type lamin C. As lamin speckle size is known to be correlated with regulation of transcription, we assessed the SUMO1 distribution pattern in the presence of mutated lamin C and showed that D192G lamin C expression totally disrupts the SUMO1 pattern. Conclusion: Our in vivo and in vitro results question the relationship of causality between LMNA mutations and the development of heart failure in some DCM patients and therefore, the reliability of genetic counselling. However, LMNA mutations producing speckles result not only in nuclear envelope structural damage, but may also lead to the dysregulation of cellular functions controlled by sumoylation, such as transcription, chromosome organisation, and nuclear trafficking.

3 February 2010 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
PGPallavi Gupta
Pallavi Gupta
ZBZofia T. Bilińska
Zofia T. Bilińska
NSNicolas Sylvius
Nicolas Sylvius
EBEmilie Boudreau
Emilie Boudreau
JVJohn P. Veinot
John P. Veinot
Frederique TessonFrederique Tesson
Frederique Tesson

2 April 2015 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
PSP W Stather
P W Stather
NSN Sylvius
N Sylvius
DSD A Sidloff
D A Sidloff
NDN Dattani
N Dattani
AVA Verissimo
A Verissimo
MBM J Bown
M J Bown